• Myeloma UK
  • Clinical Service Excellence Programme
Top menu
TwitterFacebook
Myeloma Academy
Myeloma Academy

Sign in | Register

Call us for more info on 0131 557 3332
Menu
  • Home
  • CPD & Learning
    • Myeloma Nurse Learning Programme
    • My CPD Portfolio
    • Challenging Cases
    • Close
  • Library
    • Guidelines
      • Complications
      • COVID-19 guidance
      • General haemato/oncology
      • Imaging & Analysis
      • Management & Treatment
      • Palliative Care
      • Presentation & Diagnosis
      • Related conditions
      • Close
    • Patient Support and Information
    • Medical animations
    • Close
  • Resources
    • Myeloma Drug Finder
    • Myeloma Trial Finder
    • Assessment tools
    • Myeloma Spotlight
    • Primary care education
    • Secondary care education
    • Myeloma health economic model
    • Close
  • News & Events
    • News
    • Event calendar
    • Meeting highlights
    • Close
  • CSEP
  • About Us
    • Contact Us
    • Close
MENU CLOSE back  

Daily Archives: August 11, 2014

IMWG Consensus perspectives: risk factors for progression and guidelines for monitoring and management of MGUS and smouldering myeloma

In this article, members of the International Myeloma Working Group review the available data and provide new recommendations for the management of MGUS and smouldering myeloma patients.

August 11, 2014

IMWG Consensus statement on the current status of allogeneic stem cell transplantation for myeloma

In this paper, members of the International Myeloma Working Group summarise the data from prospective and retrospective studies of allogeneic stem cell transplantation in myeloma and provide recommendations for new safer approaches whilst preserving the graft versus myeloma effect.

August 11, 2014

IMWG Recommendations for the prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

This paper, produced by the International Myeloma Working Group, summarises the available evidence and provides recommendations for a prophylaxis strategy according to a risk assessment model, to reduce the risk of a venous thromboembolic event in myeloma patients.

August 11, 2014

IMWG Management of treatment-emergent peripheral neuropathy in multiple myeloma

This paper, written by an expert panel on behalf of the International Myeloma Working Group, outlines the state of knowledge of treatment-induced peripheral neuropathy in myeloma patients and the various management practices, providing recommendations for the optimal management of patients who develop peripheral neuropathy during treatment.

August 11, 2014

Plasma cell leukaemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the IMWG

This article, written by the International Myeloma Working Group, reviews the evidence and provides a consensus on the diagnostic criteria, response criteria and treatment recommendations for primary plasma cell leukemia.

August 11, 2014
Myeloma Academy
Bottom menu

Registered Charity
No. SC 026116
Myeloma UK
22 Logie Mill
Beaverbank Business Park
Edinburgh
EH7 4HG